Position in GILD
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$792,278
-$12,026 QoQ
Shares Held
6,271
+8.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#1,171
of 2,261 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 73%
Shared 0%
None 27%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Grove Bank & Trust holds $25,083,993 across 15 Drug Manufacturers - General names. GILD ranks #8 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,571 | $9,080,885 | |
| 2 | ABBV |
AbbVie Inc.
|
15,353 | $3,863,428 | |
| 3 | JNJ |
Johnson & Johnson
|
15,184 | $3,856,280 | |
| 4 | MRK |
Merck & Co., Inc.
|
15,556 | $1,998,945 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
22,434 | $1,292,646 | |
| 6 | AMGN |
Amgen Inc
|
3,253 | $1,177,976 | |
| 7 | AZN |
Astrazeneca PLC
|
5,776 | $1,095,244 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
6,271 | $792,278 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $792,278 | 6,271 | Shares | Defined | 2026-07-07 | |
| 2026-03-31 | $804,304 | 5,771 | Shares | Defined | 2026-04-08 | |
| 2025-12-31 | $707,350 | 5,763 | Shares | Defined | 2026-01-08 | |
| 2025-09-30 | $634,143 | 5,713 | Shares | Defined | 2025-10-06 | |
| 2025-06-30 | $637,835 | 5,753 | Shares | Defined | 2025-07-11 | |
| 2025-03-31 | $631,962 | 5,640 | Shares | Defined | 2025-04-17 | |
| 2024-12-31 | $191,021 | 2,068 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $169,943 | 2,027 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $149,912 | 2,185 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $233,667 | 3,190 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $661,365 | 8,164 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $662,319 | 8,838 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $663,649 | 8,611 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $914,827 | 11,026 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $1,586,078 | 18,475 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $1,177,477 | 19,087 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $991,061 | 16,034 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $752,577 | 12,659 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $894,192 | 12,315 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $867,327 | 12,417 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $832,448 | 12,089 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $706,147 | 10,926 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $532,787 | 9,145 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $514,492 | 8,142 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $368,927 | 4,795 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $437,869 | 5,857 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||